NCT02390232View on ClinicalTrials.gov

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

CompletedOBSERVATIONAL
Enrollment

176

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
BIOLOGICAL

liver biopsy

A small needle is inserted into the liver to collect a tissue sample

BIOLOGICAL

collection of stools

collection of stools

BIOLOGICAL

blood sample

collection of blood sample

Trial Locations (1)

Unknown

CHU Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02390232 - Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH | Biotech Hunter | Biotech Hunter